Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Medical Equipment & Supplies
  6. /
  7. HSIL Limited
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksMedical Equipment & SuppliesHSIL Limited

HSIL Limited Stock Price Today (NSE: HSIL)

HSIL Limited

HSILMedical Equipment & Supplies
₹217.50₹15.40 (5.96%)↓
As on 30 Mar 2026, 12:03 pm ISTMarket Closed

Fundamental Score

...

HSIL Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

HSIL Limited share price today is ₹217.50, down 5.96% on NSE/BSE as of 30 March 2026. HSIL Limited (HSIL) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹354.57 (Cr). The 52-week high for HSIL share price is ₹367.10 and the 52-week low is ₹89.99. At a P/E ratio of 34.23x, HSIL is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 13.58% and a debt-to-equity ratio of 0.43.

HSIL Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
-5.96%

Returns & Performance

Poor

ROE

13.58%
Average

ROCE

16.35%
Poor

OPM (5Y)

8.24%

Div Yield

0.00%

HSIL Limited Valuation Check

Good

P/E Ratio

34.23x
Poor

Industry P/E

47.87x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

354.57 (Cr)

Growth Engine

Excellent

Profit Growth (Q)

70.13%
Excellent

Sales Growth (Q)

31.49%
Excellent

Sales Growth (5Y)

13.69%
Poor

EPS Growth (5Y)

-22.27%
Excellent

Profit Growth (5Y)

74.11%

Balance Sheet Health

Good

Debt to Equity

0.43x
Excellent

Int. Coverage

4.94x

Free Cash Flow (5Y)

-31.31 (Cr)

Shareholding

Excellent

Promoter

58.90%
Poor

FII

0.15%
Good

DII

10.81%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

HSIL Share Price: A Conservative Value Investor's Analysis

Within the Medical Equipment & Supplies industry, a critical factor often overlooked is the increasing consolidation of purchasing power among hospital networks and group purchasing organizations (GPOs). This trend places significant pressure on manufacturers like HSIL Limited to maintain competitive pricing and innovate constantly. This analysis examines the HSIL share price from the perspective of a conservative value investor prioritizing capital preservation.

Currently trading at ₹280.0, HSIL share price presents a PE ratio of 34.23. As a value investor, I prefer to see a lower PE ratio indicating a potentially undervalued stock. While the reported ROCE of 16.35% is respectable, its sustainability and consistency are critical factors for long-term value creation. A higher, more consistent ROCE often signifies a widening economic moat, allowing the company to generate superior returns over its peers. This needs further investigation over a longer time horizon.

Comparing HSIL Limited with its peers, such as Choksi Asia, requires a careful assessment of management quality and capital allocation decisions. While quantitative metrics are important, a qualitative understanding of the management's ability to navigate industry challenges and generate shareholder value is paramount. Are they effectively adapting to the evolving landscape dominated by larger purchasing groups? This comparative analysis requires deeper scrutiny, particularly comparing them on revenue and margin trends.

The 16.35% ROCE, if maintained, suggests HSIL Limited is generating returns above its cost of capital, which is a positive sign. However, the strength of its moat – its competitive advantage – hinges on its ability to protect this profitability. Can HSIL consistently reinvest earnings at a rate that sustains this ROCE? How effectively does it compete in terms of innovation and product differentiation to avoid price erosion? These factors are vital in determining the long-term investment appeal.

This analysis is part of a more extensive 80-parameter fundamental audit personally verified by Sweta Mishra, focusing on key aspects such as financial leverage, cash flow generation, and dividend policy. The observations presented here are based on publicly available information and are intended for informational purposes only. It is crucial to conduct thorough due diligence and consider individual investment objectives before making any investment decisions.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

HSIL Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of HSIL across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Excellent ROCE Performance (16.35%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Attractive Valuation (P/E: 34.23 vs Industry: 47.87)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (70.13%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (31.49%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (13.69% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (74.11% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Balanced Promoter Holding (58.90%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Weak Earnings Growth (-22.27% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Negative Free Cash Flow (₹-31.31 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

HSIL Limited Financial Statements

Comprehensive financial data for HSIL Limited including income statement, balance sheet and cash flow

About HSIL (HSIL Limited)

HSIL Limited is a dynamic player in the medical equipment and supplies sector, dedicated to providing high-quality solutions for healthcare professionals and patients alike. The co...mpany specializes in the comprehensive supply of essential medical products, from specialized surgical instruments to everyday medical consumables. With a strong commitment to innovation and adherence to stringent quality standards, HSIL Limited strives to meet the ever-evolving needs of the healthcare industry. This focus on excellence ensures that healthcare providers have access to reliable tools and supplies, empowering them to deliver the best possible care. HSIL Limited is constantly expanding its product portfolio and distribution network to reach a wider range of medical facilities and improve patient outcomes. The company's product range encompasses a wide variety of medical devices, diagnostic tools, and essential supplies. HSIL Limited provides a comprehensive selection of items crucial for effective diagnosis, treatment, and patient care, from sophisticated surgical instruments that demand precision to essential everyday supplies. The portfolio includes advanced diagnostic equipment, enabling healthcare professionals to detect and understand medical conditions accurately and efficiently. Understanding the critical importance of reliability in the medical field, HSIL Limited meticulously sources its products from trusted manufacturers, adhering to strict quality control protocols at every stage. This commitment to quality ensures the safety and efficacy of all products, instilling confidence in healthcare providers who rely on HSIL Limited's offerings. Beyond supplying medical equipment, HSIL Limited prioritizes exceptional customer service and builds lasting partnerships with healthcare providers. The company prides itself on understanding the unique needs of each customer and tailoring solutions accordingly. HSIL Limited's team of experienced professionals offers expert guidance and support, ensuring that clients can make informed decisions about the products they require. By focusing on building strong relationships, the company has earned a reputation for reliability and trustworthiness within the medical community. HSIL Limited is dedicated to contributing to the advancement of healthcare by providing innovative products and unparalleled customer support.

Company Details

Symbol:HSIL
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies
Website:https://www.hemantsurgical.com

Key Leadership

Mr. Hanskumar Shamji Shah
Chairman & MD
Mr. Kaushik Hanskumar Shah
CFO & Whole-Time Director
Ms. Meenal Patodia
Company Secretary & Compliance Officer

Latest News

Uttarakhand Cloudburst Live Updates: Rescuers search for the missing in flood-hit Dharali; Dhami does helicopter survey - Times of India
Times of India• 8/6/2025
Closing Bell: Nifty ends above 11,850, Sensex jumps 448 pts led by financial, metal stocks - Moneycontrol
Moneycontrol• 10/19/2020
Bullish on HSIL and Dish TV: Vikas Sethi - MD, Sethi Finmart Pvt Ltd - The Economic Times
The Economic Times• 6/3/2015

HSIL Share Price: Frequently Asked Questions

What is the current share price of HSIL Limited (HSIL)?

As of 30 Mar 2026, 12:03 pm IST, HSIL Limited share price is ₹217.50. The HSIL stock has a market capitalisation of ₹354.57 (Cr) on NSE/BSE.

Is HSIL share price Overvalued or Undervalued?

HSIL share price is currently trading at a P/E ratio of 34.23x, compared to the industry average of 47.87x. Based on this relative valuation, the HSIL Limited stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of HSIL share price?

The 52-week high of HSIL share price is ₹367.10 and the 52-week low is ₹89.99. These values are updated daily from NSE/BSE price data.

What factors affect the HSIL Limited share price?

Key factors influencing HSIL share price include quarterly earnings growth (Sales Growth: 31.49%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is HSIL Limited a good stock for long-term investment?

HSIL Limited shows a 5-year Profit Growth of 74.11% and an ROE of 13.58%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.43 before investing in HSIL shares.

How does HSIL Limited compare with its industry peers?

HSIL Limited competes with major peers in the Medical Equipment & Supplies. Investors should compare HSIL share price P/E of 34.23x and ROE of 13.58% against the industry averages to determine competitive standing.

What is the P/E ratio of HSIL and what does it mean?

HSIL share price has a P/E ratio of 34.23x compared to the industry average of 47.87x. Investors pay ₹34 for every ₹1 of annual earnings.

How is HSIL performing according to Bull Run's analysis?

HSIL has a Bull Run fundamental score of 61.2/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does HSIL belong to?

HSIL operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting HSIL Limited share price.

What is Return on Equity (ROE) and why is it important for HSIL?

HSIL has an ROE of 13.58%, which shows decent profitability but room for improvement. ROE measures how efficiently HSIL Limited generates profits from shareholders capital.

How is HSIL debt-to-equity ratio and what does it indicate?

HSIL has a debt-to-equity ratio of 0.43, which indicates moderate leverage that should be monitored.

What is HSIL dividend yield and is it a good dividend stock?

HSIL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in HSIL Limited shares.

How has HSIL share price grown over the past 5 years?

HSIL has achieved 5-year growth rates of: Sales Growth 13.69%, Profit Growth 74.11%, and EPS Growth -22.27%.

What is the promoter holding in HSIL and why does it matter?

Promoters hold 58.90% of HSIL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in HSIL Limited.

What is HSIL market capitalisation category?

HSIL has a market capitalisation of ₹355 crores, placing it in the Small-cap category.

How volatile is HSIL stock?

HSIL has a beta of N/A. A beta > 1 suggests the HSIL Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is HSIL operating profit margin trend?

HSIL has a 5-year average Operating Profit Margin (OPM) of 8.24%, indicating the company's operational efficiency.

How is HSIL quarterly performance?

Recent quarterly performance shows HSIL Limited YoY Sales Growth of 31.49% and YoY Profit Growth of 70.13%.

What is the institutional holding pattern in HSIL?

HSIL has FII holding of 0.15% and DII holding of 10.81%. Significant institutional holding often suggests professional confidence in the HSIL Limited stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about HSIL Limited

What is the current share price of HSIL Limited?

HSIL Limited (HSIL) trades at ₹217.50 on NSE and BSE. Market cap ₹354.57 (Cr). Educational data only.

What is the P/E ratio of HSIL Limited?

HSIL Limited has a P/E of 34.23x vs industry average 47.87x.

What is the Bull Run score for HSIL Limited?

HSIL Limited has a Bull Run score of 61.2/100 based on 25+ financial parameters.

Does HSIL Limited pay dividends?

HSIL Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of HSIL Limited?

HSIL Limited has ROE of 13.58%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of HSIL Limited?

HSIL Limited has debt-to-equity of 0.43.

Is HSIL Limited a good investment?

Bull Run gives HSIL Limited a score of 61.2/100. This is not investment advice — consult a SEBI-registered advisor.